, Tracking Stock Market Picks
Enter Symbol:

down 91.84 %

ENTEROMEDICS INC. (ETRM) rated Outperform with price target $4.50 by Northland Securities

Posted on: Friday,  Jun 29, 2012  8:25 AM ET by Northland Securities

Northland Securities rated Outperform ENTEROMEDICS INC. (NASDAQ: ETRM) on 06/29/2012, when the stock price was $3.31. Since
then, ENTEROMEDICS INC. has lost 91.84% as of 01/13/2016's recent price of $0.27.
If you would have followed this Northland Securities's recommendation on ETRM, you would have lost 91.84% of your investment in 1293 days.

EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of how the vagus nerve affects food intake and processing, EnteroMedics has selected obesity management as its primary focus.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/29/2012 8:25 AM Buy
3.31 4.50
as of 12/31/2012
1 Week up  15.70 %
1 Month down  -9.67 %
3 Months down  -23.28 %
1 YTD down  -15.40 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy